
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AME | 1,268 | 52.6% | -0.96 | 652 | 65.5% |
| Optic-unspecified | 979 | 40.6% | -2.17 | 217 | 21.8% |
| CentralBrain-unspecified | 140 | 5.8% | -0.18 | 124 | 12.4% |
| ME | 24 | 1.0% | -3.00 | 3 | 0.3% |
| upstream partner | # | NT | conns aMe6b | % In | CV |
|---|---|---|---|---|---|
| HBeyelet | 7 | HA | 330.5 | 28.2% | 0.1 |
| aMe6c | 3 | Glu | 302 | 25.7% | 0.1 |
| aMe1 | 4 | GABA | 137.5 | 11.7% | 0.1 |
| MeVCMe1 | 4 | ACh | 103.5 | 8.8% | 0.3 |
| aMe5 | 27 | ACh | 78.5 | 6.7% | 0.9 |
| MeVPMe12 | 4 | ACh | 73 | 6.2% | 0.4 |
| OA-AL2i3 | 4 | OA | 44.5 | 3.8% | 0.3 |
| aMe23 | 2 | Glu | 16 | 1.4% | 0.0 |
| aMe10 | 3 | ACh | 10.5 | 0.9% | 0.3 |
| aMe4 | 11 | ACh | 9.5 | 0.8% | 0.3 |
| aMe22 | 2 | Glu | 9 | 0.8% | 0.0 |
| aMe30 | 4 | Glu | 6.5 | 0.6% | 0.5 |
| aMe6a | 1 | ACh | 4.5 | 0.4% | 0.0 |
| aMe_TBD1 | 2 | GABA | 4 | 0.3% | 0.0 |
| MeVPaMe1 | 2 | ACh | 3.5 | 0.3% | 0.0 |
| aMe2 | 3 | Glu | 3.5 | 0.3% | 0.3 |
| Mi1 | 2 | ACh | 3 | 0.3% | 0.7 |
| Dm9 | 1 | Glu | 2.5 | 0.2% | 0.0 |
| aMe12 | 3 | ACh | 2.5 | 0.2% | 0.6 |
| Dm10 | 3 | GABA | 2.5 | 0.2% | 0.3 |
| LoVC23 | 2 | GABA | 2.5 | 0.2% | 0.0 |
| SLP249 | 3 | Glu | 2 | 0.2% | 0.2 |
| l-LNv | 2 | unc | 2 | 0.2% | 0.0 |
| aMe15 | 1 | ACh | 1.5 | 0.1% | 0.0 |
| MeVP11 | 2 | ACh | 1.5 | 0.1% | 0.3 |
| Lat3 | 1 | unc | 1 | 0.1% | 0.0 |
| C2 | 1 | GABA | 1 | 0.1% | 0.0 |
| MeLo6 | 1 | ACh | 1 | 0.1% | 0.0 |
| Lat1 | 1 | unc | 1 | 0.1% | 0.0 |
| Cm35 | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm21 | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe_unclear | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi15 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeLo7 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe9 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm23 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Lat2 | 1 | unc | 0.5 | 0.0% | 0.0 |
| s-LNv | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPaMe2 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm25 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP59 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC21 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| PLP211 | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVPMe13 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm20 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeLo1 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe24 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LT58 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPLo1 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC22 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm31a | 1 | GABA | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns aMe6b | % Out | CV |
|---|---|---|---|---|---|
| aMe4 | 19 | ACh | 379.5 | 24.3% | 0.3 |
| aMe1 | 4 | GABA | 186 | 11.9% | 0.1 |
| MeVPMe12 | 4 | ACh | 126 | 8.1% | 0.2 |
| aMe5 | 28 | ACh | 92.5 | 5.9% | 1.3 |
| aMe10 | 3 | ACh | 91 | 5.8% | 0.3 |
| aMe17b | 5 | GABA | 87 | 5.6% | 0.1 |
| aMe15 | 2 | ACh | 69 | 4.4% | 0.0 |
| l-LNv | 8 | unc | 46 | 2.9% | 0.6 |
| Lat2 | 4 | unc | 46 | 2.9% | 0.2 |
| MeVPaMe2 | 2 | Glu | 45.5 | 2.9% | 0.0 |
| aMe6c | 3 | Glu | 44.5 | 2.8% | 0.2 |
| MeVP29 | 2 | ACh | 35.5 | 2.3% | 0.0 |
| aMe30 | 4 | Glu | 31.5 | 2.0% | 0.2 |
| aMe3 | 2 | Glu | 29.5 | 1.9% | 0.0 |
| OA-AL2i3 | 4 | OA | 29 | 1.9% | 0.3 |
| aMe_TBD1 | 2 | GABA | 28.5 | 1.8% | 0.0 |
| 5thsLNv_LNd6 | 4 | ACh | 15 | 1.0% | 0.4 |
| SLP250 | 2 | Glu | 14.5 | 0.9% | 0.0 |
| s-LNv | 7 | ACh | 14 | 0.9% | 0.5 |
| Cm35 | 2 | GABA | 11 | 0.7% | 0.0 |
| aMe13 | 2 | ACh | 9.5 | 0.6% | 0.0 |
| aMe_unclear | 1 | Glu | 8.5 | 0.5% | 0.0 |
| aMe23 | 2 | Glu | 8.5 | 0.5% | 0.0 |
| Lat1 | 6 | unc | 8.5 | 0.5% | 0.6 |
| SLP249 | 3 | Glu | 7.5 | 0.5% | 0.1 |
| aMe2 | 6 | Glu | 6 | 0.4% | 0.4 |
| Mi18 | 2 | GABA | 5.5 | 0.4% | 0.6 |
| MeVPaMe1 | 2 | ACh | 5 | 0.3% | 0.0 |
| HBeyelet | 7 | HA | 5 | 0.3% | 0.3 |
| Lawf1 | 3 | ACh | 4.5 | 0.3% | 0.9 |
| aMe26 | 4 | ACh | 4.5 | 0.3% | 0.2 |
| CL125 | 4 | Glu | 4.5 | 0.3% | 0.3 |
| MeVC21 | 4 | Glu | 4 | 0.3% | 0.3 |
| LoVP53 | 2 | ACh | 4 | 0.3% | 0.0 |
| aMe12 | 4 | ACh | 4 | 0.3% | 0.3 |
| aMe17c | 3 | Glu | 3.5 | 0.2% | 0.4 |
| aMe6a | 2 | ACh | 3.5 | 0.2% | 0.0 |
| aMe8 | 1 | unc | 2.5 | 0.2% | 0.0 |
| MeVPMe13 | 1 | ACh | 2.5 | 0.2% | 0.0 |
| Cm1 | 3 | ACh | 2.5 | 0.2% | 0.3 |
| MeVC20 | 4 | Glu | 2.5 | 0.2% | 0.2 |
| aMe24 | 1 | Glu | 2 | 0.1% | 0.0 |
| C2 | 3 | GABA | 2 | 0.1% | 0.2 |
| Lat3 | 2 | unc | 2 | 0.1% | 0.0 |
| MeLo7 | 2 | ACh | 1.5 | 0.1% | 0.3 |
| Lat5 | 2 | unc | 1.5 | 0.1% | 0.0 |
| aMe22 | 2 | Glu | 1.5 | 0.1% | 0.0 |
| MeLo6 | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm11d | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP31 | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP59 | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP51 | 1 | Glu | 1 | 0.1% | 0.0 |
| DNp27 | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP8 | 2 | ACh | 1 | 0.1% | 0.0 |
| MeVC22 | 2 | Glu | 1 | 0.1% | 0.0 |
| Dm2 | 2 | ACh | 1 | 0.1% | 0.0 |
| Tm20 | 2 | ACh | 1 | 0.1% | 0.0 |
| DNpe053 | 2 | ACh | 1 | 0.1% | 0.0 |
| MeVC23 | 2 | Glu | 1 | 0.1% | 0.0 |
| MeVCMe1 | 2 | ACh | 1 | 0.1% | 0.0 |
| Tm5a | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm9 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Mi10 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm38 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP1 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP7 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC_unclear | 1 | Glu | 0.5 | 0.0% | 0.0 |
| SMP200 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP63 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVC24 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe20 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm30 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVP49 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| OA-AL2i4 | 1 | OA | 0.5 | 0.0% | 0.0 |
| aMe17e | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP3 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeLo2 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP39 | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Cm24 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe4 | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LoVP54 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP28 | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe17a | 1 | unc | 0.5 | 0.0% | 0.0 |